SAPIRSTEIN JAMES 4
4 · First Wave BioPharma, Inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock option (right to buy)
2022-01-03+150,000→ 150,000 totalExercise: $1.45Exp: 2032-01-03→ Common stock, par value $0.0001 per share (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Sapirstein's continued employment by First Wave BioPharma, Inc. on the applicable vesting date.